Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected ...

Last month's precipitation improved Utah's water outlook somewhat, but Lake Powell's and Great Salt Lake's tributaries are ...

You’ll never compromise with the new RZR Trail S. Tighten every turn with the stability and traction of a perfectly balanced trail vehicle. Shorten the distance between turns with immediate ...

Save 5% on FUT coins using my code "MattHD" at <a href="https://bit.ly/MMOexp-MattHD">https://bit.ly/MMOexp-MattHD</a> I Built this FIFA 23 Shapeshifters Team in 5 Hours... How to Build THIS team in 5 ...

Advanced Global Phase 3 Program for Treatment of Hepatitis C Virus (HCV) in 2025 with Topline Results from North American C-BEYOND Trial Expected Mid-2026 and Topline Results from C-FORWARD Trial Outs ...

The agreement comes after the deployment of lasers led the FAA to suddenly close airspace in Texas twice in the last month.

Loved ones are speaking out after a man who was reportedly denied medical care later died while in custody at an ICE detention center in Adelanto. KTLA's Carlos ...

Together, Pennzoil and Team Penske partner to build championships, and underlying that drive is motor oil that delivers for consumers, too. Read more here.

TRAVEL TO GO THE DISTANCE: Turbo S-inspired, high-strength trailing arms with a segment leading 25” of usable travel offer relentless durability and performance to handle demanding terrain. POWER YOUR ...

Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2025 Earnings Call Transcript March 5, 2026 Atea Pharmaceuticals, Inc. misses on ...

Good afternoon, everyone, and welcome to the Atea Pharmaceuticals' Fourth Quarter 2025 Financial Results and Business Update Conference Call. [Operator Instructions] I would now like to turn the call ...

Cash and Investments -- $301.8 million as of December 31, 2025, sufficient to fully fund current Phase III HCV and new HEV programs through 2027. Phase III HCV Trials -- C BEYOND enrollment completed ...